$ASTI

Ascent Solar Technologies, Inc.

CIK:0001350102|SEC Filings

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Total Revenues	$ 95,203	$ 16,961	$ 147,147	$ 32,585
Costs and Expenses
Costs of revenue	160,795	28,608	231,532	52,723
Research, development and manufacturing operations	697,297	622,921	1,391,525	1,174,593
Selling, general and administrative	1,072,058	1,032,825	2,512,525	1,990,676
Share-based compensation	89,605	404,219	177,091	615,726
Depreciation and amortization	20,950	17,442	42,427	34,352
Total Costs and Expenses	2,040,705	2,106,015	4,355,100	3,868,070
Loss from Operations	(1,945,502)	(2,089,054)	(4,207,953)	(3,835,485)
Other Income/(Expense)
Other income/(expense), net	130,517	37,395	229,457	124,781
Interest expense	(12,159)	(12,159)	(24,184)	(27,410)
Total Other Income/(Expense)	118,358	25,236	205,273	97,371
Income/(Loss) on Equity Method Investments	560	(1,579)	(1,066)	(1,579)
Net Income/(Loss)	(1,826,584)	(2,065,397)	(4,003,746)	(3,739,693)
Less: Series 1C preferred stock dividends	(20,203)	(49,159)	(40,632)	(102,227)
Net Income/(Loss) Available to Common Shareholders	$ (1,846,787)	$ (2,114,556)	$ (4,044,378)	$ (3,841,920)
Net Income/(Loss) Per Share (Basic)	$ (0.19)	$ (1.17)	$ (0.46)	$ (2.33)
Net Income/(Loss) Per Share (Diluted)	$ (0.19)	$ (1.17)	$ (0.46)	$ (2.33)
Weighted Average Common Shares Outstanding (Basic)	9,587,205	1,802,501	8,782,811	1,645,767
Weighted Average Common Shares Outstanding (Diluted)	9,587,205	1,802,501	8,782,811	1,645,767
Other Comprehensive Income/(Loss)
Foreign currency translation gain/(loss)	$ (244)	$ 5,334	$ (1,915)	$ 7,832
Net Comprehensive Income/(Loss)	(1,826,828)	(2,060,063)	(4,005,661)	(3,731,861)
Products
Total Revenues	$ 95,203	$ 16,961	124,147	$ 32,585
Milestone and engineering
Total Revenues			$ 23,000

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Operating Activities:
Net income/(loss)	$ (4,003,746)	$ (3,739,693)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	42,427	34,352
Share-based compensation	177,004	615,492
Operating lease asset amortization	301,212	265,343
Amortization of debt discount	0	2,780
Loss on equity method investment	1,066	1,579
Inventory reserve expense	35,372	(8,286)
Gain on settlement of liability, net	0	(35,039)
Changes in operating assets and liabilities:
Accounts receivable	(32,250)	(12,821)
Inventories	(43,640)	3,508
Prepaid expenses and other current assets	(123,536)	(134,099)
Accounts payable	24,498	138,146
Operating lease liabilities	(328,203)	(280,450)
Accrued interest	24,184	24,184
Accrued expenses	116,490	(236,540)
Net cash used in operating activities	(3,809,122)	(3,361,544)
Investing Activities:
Payments on purchase of assets	0	(2,515)
Cost investment purchase	(200,000)	0
Net cash used in investing activities	(200,000)	(2,515)
Financing Activities:
Repayment of bridge loans	0	(22,335)
Proceeds from issuance of Common Stock	9,999,923	3,566,594
Financing issuance cost	(799,284)	(396,084)
Exercise of warrants	6,931,053	0
Exercised PIPE warrants cost	(401,267)	0
Exercised options	30,430	0
Net cash provided by (used in) financing activities	15,760,855	3,148,175
Net change in cash and cash equivalents	11,751,733	(215,884)
Cash and cash equivalents at beginning of period	2,786,493	3,170,743
Cash and cash equivalents at end of period	14,538,226	2,954,859
Supplemental disclosure of cash flow information:
Interest	$ 0	$ 446

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 14,538,226	$ 2,786,493
Trade receivables, net of allowance of $0 and $0, respectively	32,250	0
Inventories, net	551,885	543,617
Prepaid and other current assets	178,105	54,569
Total current assets	15,300,466	3,384,679
Property, Plant and Equipment:	19,059,301	19,132,627
Accumulated depreciation	(18,910,960)	(18,942,542)
Property, Plant and Equipment, net	148,341	190,085
Other Assets:
Operating lease right-of-use assets, net	1,031,220	1,332,432
Patents, net of accumulated amortization of $141,872 and $141,189 respectively	8,448	9,131
Equity method investment	66,240	69,221
Other investment	275,000	75,000
Other non-current assets	1,271,355	1,271,355
Total other assets	2,652,263	2,757,139
Total Assets	18,101,070	6,331,903
Current Liabilities:
Accounts payable	419,199	394,701
Related party payables	5,769	5,769
Accrued expenses	188,373	240,857
Accrued payroll	321,138	211,275
Accrued professional services fees	121,150	62,039
Accrued interest	638,725	614,541
Current portion of operating lease liability	730,769	676,595
Total current liabilities	2,425,123	2,205,777
Long-Term Liabilities:
Non-current operating lease liabilities	405,900	788,277
Total liabilities	2,831,023	2,994,054
Commitments and contingencies (Note 12)
Stockholders' Equity:
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($1,020,923 and $996,739 Liquidation Preference, respectively)	5	5
Common stock, $0.0001 par value, 200,000,000 authorized; 9,816,431 and 4,662,208 shares issued and outstanding, respectively	982	466
Additional paid in capital	518,703,372	502,766,029
Accumulated deficit	(503,445,211)	(499,441,465)
Accumulated other comprehensive loss	10,899	12,814
Total stockholders' equity	15,270,047	3,337,849
Total Liabilities and Stockholders' Equity	$ 18,101,070	$ 6,331,903